Furthermore, authors suggested that TLR4 pathway may mediate hyperandrogenism-induced chronic low-grade inflammation in PCOS mice, possibly by leading to the activation of NLRP3 inflammasome via the downstream signaling molecule MyD88 and activation of NF-κB [69, 130]. The gene discussed is NLRP3; the disease is hyperandrogenism.